These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6850650

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET, Ahmann DL, Schutt AJ, Green SJ.
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [Abstract] [Full Text] [Related]

  • 23. Clinical correlations of in vitro drug sensitivity.
    Salmon SE, Alberts DS, Meyskens FL, Durie BG, Jones SE, Soehnlen B, Young L, Chen HS, Moon TE.
    Prog Clin Biol Res; 1980 Jun; 48():223-45. PubMed ID: 7193872
    [No Abstract] [Full Text] [Related]

  • 24. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ, Hill GJ.
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [Abstract] [Full Text] [Related]

  • 25. [Brain metastases of malignant melanomas].
    Boaziz C, Breau JL, Morere JF, Israël L.
    Bull Cancer; 1991 Mar; 78(4):347-53. PubMed ID: 1859902
    [Abstract] [Full Text] [Related]

  • 26. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V, Sausville EA, Camalier RF, Fiebig HH, Burger AM.
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [Abstract] [Full Text] [Related]

  • 27. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE, Roos IA, Hillcoat BL.
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [Abstract] [Full Text] [Related]

  • 28. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC, Peacock JH.
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [Abstract] [Full Text] [Related]

  • 29. Soft agar clonogenic assay for predicting chemosensitivity of human tumor cells from malignant effusions.
    Ballet F, Petit J, Poupon R, Darnis F.
    Biomedicine; 1981 Nov; 35(6):177-8. PubMed ID: 7337802
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997 Nov; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

  • 32. [Uptake of radioactive precursors for the evaluation of sensitivity of anticancer drugs against cancer cells].
    Ichihashi H, Kondo T.
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1130-8. PubMed ID: 6471419
    [Abstract] [Full Text] [Related]

  • 33. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B, Sibamoto J, Abe M.
    Srp Arh Celok Lek; 1996 Jul; 124(7-8):169-74. PubMed ID: 9102841
    [Abstract] [Full Text] [Related]

  • 34. [In vitro chemosensitivity assay using a double-layer-agar system: human tumor cloning assay and thymidine incorporation assay].
    Tanigawa N, Shimomatsuya T, Fujii H, Yamakawa M, Muraoka R, Saitoh H.
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):440-6. PubMed ID: 8452381
    [Abstract] [Full Text] [Related]

  • 35. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS, Mackel C, Pocelinko R, Salmon SE.
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [Abstract] [Full Text] [Related]

  • 36. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea].
    Kubota R, Kubota K, Yamada S.
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2169-74. PubMed ID: 1444482
    [Abstract] [Full Text] [Related]

  • 37. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.
    Park CH, Wiernik PH, Morrison FS, Amare M, Van Sloten KV, Maloney TR.
    Cancer Res; 1983 May; 43(5):2346-9. PubMed ID: 6572563
    [Abstract] [Full Text] [Related]

  • 38. [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma].
    Fischel JL, Barbé V, Berlion M, Formento P, Berrile J, Bizzari JP, Milano G.
    Bull Cancer; 1994 Jul; 81(7):599-604. PubMed ID: 7742602
    [Abstract] [Full Text] [Related]

  • 39. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
    Dykes DJ, Griswold DP, Schabel FM.
    Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
    [Abstract] [Full Text] [Related]

  • 40. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D, Worm M, Algermissen B, Kohlmus CM, Czarnetzki BM.
    Cancer; 1994 Jan 01; 73(1):103-8. PubMed ID: 7506115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.